Novo Nordisk

Novo Nordisk Has One of the Widest Moats in Health Care
Yahoo/Morningstar
Thu, 06/6/13 - 10:04 am
Novo Nordisk
diabetes
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
Is Novo A Threat To Arena, Vivus, And Orexigen?
Seeking Alpha
Thu, 05/30/13 - 09:02 am
obesity
Novo Nordisk
Victoza
Arena Pharmaceuticals
Vivus
Orexigen
Novo obesity drug could launch in U.S. end 2014
Reuters
Fri, 05/24/13 - 10:40 am
Novo Nordisk
liraglutide
obesity
weight loss
Positive Data on Novo Nordisk's N9-GP
Yahoo/Zacks
Wed, 05/22/13 - 09:41 am
Novo Nordisk
N9-GP
hemophilia B
Novo Nordisk completes PhIII hemophilia trial with positive results
Fierce Biotech
Fri, 05/17/13 - 12:01 pm
Novo Nordisk
hemophilia B
N9-GP
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
obesity
Novo Nordisk
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Victoza
Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says
Fierce Pharma
Thu, 05/9/13 - 09:48 am
Novo Nordisk
Victoza
Tresiba
diabetes
Novo Nordisk First-Quarter Profit Climbs on Insulins, Victoza
Bloomberg
Wed, 05/1/13 - 09:04 am
Novo Nordisk
earnings
Trounce the Market With This Diabetes Care Company
Motley Fool
Mon, 04/29/13 - 10:46 am
diabetes
Novo Nordisk
Novo Nordisk Unveils New U.S. Headquarters
Yahoo
Fri, 04/19/13 - 12:25 pm
Novo Nordisk
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thu, 04/18/13 - 10:43 am
adverse events
diabetes
FDA
Novo Nordisk
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Eli Lilly
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
Wed, 04/17/13 - 04:40 pm
diabetes
Eli Lilly
dulaglutide
Novo Nordisk
Sanofi
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thu, 03/28/13 - 10:23 am
JNJ
FDA
Invokana
AstraZeneca
Bristol-Myers Squibb
Merck
Sanofi
Novo Nordisk
Novartis
4 Stocks Dragging The Drugs Industry Downward
TheStreet.com
Thu, 03/28/13 - 08:52 am
Novo Nordisk
Teva
Sanofi
Novartis
Novo Lures Sanofi Pitchman as Diabetes Battle Heats Up
Bloomberg
Wed, 03/27/13 - 10:26 am
Sanofi
Novo Nordisk
diabetes
Drug Manufacturing Stocks Tumble on FDA Concerns
Yahoo/Accesswire
Fri, 03/22/13 - 10:49 am
drug manufacturing
Depomed
Novo Nordisk
Novo Nordisk’s Oral Insulin Successfully Completes Early Study
Bloomberg
Wed, 03/20/13 - 11:54 am
insulin
Novo Nordisk
diabetes
Merrion
Novo Nordisk obesity drug results underwhelm investors
Reuters
Tue, 03/19/13 - 11:02 am
obesity
Novo Nordisk
liraglutide

Pages